Ironwood Pharmaceuticals | Capital Ordinaire

Prix De L'Action
3.42
Variation Quotidienne
-0.24 -6.56%
Mensuellement
-28.60%
Annuel
112.42%
Q1 Prévisions
3.32




Capital Ordinaire Changement Date
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Agios Pharmaceuticals USD 58.45M 169K 2025-12
Akebia Therapeutics USD 2K 0 2025-03
Almirall EUR 214.79M 0 2025-12
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Amarin USD 20.8M 28K 2025-09
Ardelyx USD 238.02M 1.13M 2024-12
Astellas Pharma JPY 1.79B 195K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Charles River Laboratories USD 49.22M 2K 2025-12
Coherus Biosciences USD 12K 0 2025-03
Emergent BioSolutions USD 100K 0 2023-06
Esperion Therapeutics USD 112K 11K 2023-09
Exact Sciences USD 189.45M 232K 2025-09
Halozyme Therapeutics USD 117.78M 259K 2025-12
Incyte USD 198.46M 2.33M 2025-12
Ironwood Pharmaceuticals USD 160K 0 2024-12
Karyopharm Therapeutics USD 13K 0 2024-09
MacroGenics USD 63.26M 62.63M 2025-09
Moderna USD 391M 2M 2025-09
Myriad Genetics USD 93.1M 0 2025-09
Pacira USD 41.12M 1.85M 2025-12
PTC Therapeutics USD 81.47M 1.54M 2025-12
Puma Biotechnology USD 5K 0 2024-06
Sarepta Therapeutics USD 104.96M 196K 2025-12
Takeda JPY 1.58B 2K 2025-12
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vanda Pharmaceuticals USD 58K 0 2024-12


Ironwood Pharmaceuticals Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.